US Sues AmerisourceBergen Claiming Suspicious Opioid Orders (2)

December 29, 2022, 5:30 PM UTC

AmerisourceBergen Corp. was sued by the US for allegedly contributing to the opioid epidemic by failing to report suspicious orders for controlled substances since 2014.

The drug distributor “repeatedly refused or negligently failed to report suspicious orders placed by pharmacy customers that defendants had reason to know were allowing opioids and other controlled substances to be diverted into illegal channels,” the government said in a civil complaint filed Thursday in federal court in Philadelphia.

The case could result in fines in the billions of dollars, a Justice Department official said in a background call with press. The distributor, which is ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.